BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18819233)

  • 1. [Physiopathologic aspects of anemia and thrombocytopenia in children with cancers: the roles of erythropoietin and thrombopoietin].
    Corazza FV
    Bull Mem Acad R Med Belg; 2008; 163(1-2):152-6; discussion 156-7. PubMed ID: 18819233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
    Wang W; Zhang MH; Yu Y; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haematological abnormalities in early abstinent alcoholics are closely associated with alterations in thrombopoietin and erythropoietin serum profiles.
    Schmitt M; Gleiter CH; Nichol JL; Pralle L; Hasselblatt M; Poser W; Ehrenreich H
    Thromb Haemost; 1999 Nov; 82(5):1422-7. PubMed ID: 10595631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.
    Rios R; Sangro B; Herrero I; Quiroga J; Prieto J
    Am J Gastroenterol; 2005 Jun; 100(6):1311-6. PubMed ID: 15929762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional erythropoietin receptor is necessary for the action of thrombopoietin on erythroid cells lacking c-mpl.
    Rouleau C; Cui K; Feldman L
    Exp Hematol; 2004 Feb; 32(2):140-8. PubMed ID: 15102474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous thrombopoietin levels during the clinical management of acute myeloid leukaemia.
    Gonen C; Haznedaroglu IC; Aksu S; Koca E; Göker H; Büyükaşik Y; Sayinalp N; Ozcebe O; Dündar S
    Platelets; 2005 Feb; 16(1):31-7. PubMed ID: 15763894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mice overexpressing murine thrombopoietin develop myelofibrosis and osteosclerosis.
    Kakumitsu H; Kamezaki K; Shimoda K; Karube K; Haro T; Numata A; Shide K; Matsuda T; Oshima K; Harada M
    Leuk Res; 2005 Jul; 29(7):761-9. PubMed ID: 15927672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-erythropoietin and anti-thrombopoietin antibodies induced after administration of recombinant human erythropoietin.
    Shin SK; Pack SP; Oh JG; Kang NK; Chang MH; Chung YH; Kim SJ; Lee JW; Heo TH
    Int Immunopharmacol; 2011 Dec; 11(12):2237-41. PubMed ID: 22051973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.
    Tsopra OA; Ziros PG; Lagadinou ED; Symeonidis A; Kouraklis-Symeonidis A; Thanopoulou E; Angelopoulou MK; Vassilakopoulos TP; Pangalis GA; Zoumbos NC
    Acta Haematol; 2009; 121(4):187-95. PubMed ID: 19468203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A family with hereditary thrombocythaemia and normal genes for thrombopoietin and c-Mpl.
    Tecuceanu N; Dardik R; Rabizadeh E; Raanani P; Inbal A
    Br J Haematol; 2006 Nov; 135(3):348-51. PubMed ID: 16995886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia in cancer patients.
    Ludwig H; Fritz E
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):2-6. PubMed ID: 9671322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombocytopenia associated with chronic liver disease.
    Afdhal N; McHutchison J; Brown R; Jacobson I; Manns M; Poordad F; Weksler B; Esteban R
    J Hepatol; 2008 Jun; 48(6):1000-7. PubMed ID: 18433919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a fusion protein between N-terminal 153 peptide of thrombopoietin and erythropoietin.
    Lu B; Liu X; Huang P
    Sci China C Life Sci; 1998 Aug; 41(4):426-34. PubMed ID: 18726261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scope of growth factor in cancer patients.
    Parvez T; Almazaini A; Al Bouq Y; Al-Hazmi OA; Al-Ahmadi YM
    J Coll Physicians Surg Pak; 2005 Jun; 15(6):375-7. PubMed ID: 15924849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To give or not to give recombinant EPO to anemia endangered cancer patients.
    Sulkowska M; Wincewicz A; Chabowska A; Kanczuga-Koda L; Szymanska M; Koda M; Witkowska E; Sulkowski S
    Prague Med Rep; 2006; 107(3):281-9. PubMed ID: 17385400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of thrombopoietin (TpO) on human erythropoiesis. In vitro studies--clinical implications].
    Machaliński B; Marlicz W; Płuciennik E; Ratajczak J; Ratajczak MZ
    Pol Arch Med Wewn; 1997 Apr; 97(4):307-15. PubMed ID: 9411407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the liver in the production of thrombopoietin compared with erythropoietin.
    Jelkmann W
    Eur J Gastroenterol Hepatol; 2001 Jul; 13(7):791-801. PubMed ID: 11474308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin level in patients with acute leukaemia.
    Pavlović-Kentera V; Stefanović S; Milenković P; Jancić M; Biljanović-Paunović L
    Haematologia (Budap); 1976; 10(3-4):455-62. PubMed ID: 1072211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis.
    Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T
    Exp Hematol; 2008 Oct; 36(10):1337-42. PubMed ID: 18619724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erythropoietin: indications and measurement].
    Klein E; Georges A; Brossaud J; Bosredon Kd; Bordenave L; Corcuff JB
    Ann Biol Clin (Paris); 2009; 67(5):505-15. PubMed ID: 19789122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.